Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenqu Xiaoshi Oral Liquid vs Domperidone for Functional Dyspepsia in Children
NCT05030116Phase 4Completed
- Sponsor
- Ruijin Hospital
- Start
- Jun 2019
- Primary completion
- May 2020
- Modality
- Microbiome Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of shen qu xiao shi oral liquid in functional dyspepsia (FD), sponsored by Ruijin Hospital. Started Jun 2019; status: completed.
02
Drugs
shen qu xiao shi oral liquid
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT05030116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05030116.